Anti-hepatitis Agents

Random Miscellaneous Quiz

Can you name the Anti-hepatitis Agents?

Quiz not verified by Sporcle

embed
 plays        
How to Play
HintAnswer
Group MOA: Competively inhibit HBV DNA polymerase +/- incorporate into viral DNA causing chain termination. Phosphorylated to active forms intracellularly by cellular kinases.
Use: The most potent anti-HBV agent. Adults only
MOA: A thymidine analog
PEG-IFN α-2a/2b class
MOA: A guanisine analog. Inhibits all 3 functions of HBV RNA-dependent DNA polymerase (base priming, reverse transcription of the -strand, synthesis of the + strand of HBV DNA.
Tenofovir Class
SE: Increased pancreatitis in HIV/HBV pts. Emergence of resistance (mutations of DNA polymerase)
Use: Lamivudine-resistant HBV. Adults only
Group P-kinetics: Pills once a day for a year or longer
IFN α-2a/2b class
MOA: An adenosine analogue. Structurally similar to adefovir.
Use: HBV treatment adults only
MOA: A cytosine analogue
P-kinetics: Oral (TID). P450 substrates (potential rx interactions)
SE: Anemia, neutropenia, dysgeusia, skin rash (esp. telaprevir), increased QT intervals (telaprevir)
Group MOA: 3 major enzymes are activated by IFN-JNK/STAT signaling pathway: (1) 2',5' oligo A synthase: produces 2'5' oligo A.
Adefovir dipivoxil (Hepsera) Class
Group MOA cont. (2) Ribonuclease L (activated by 2'5' oligo A): degrades mRNA.
SE: HA, fatigue, nausea. Potential mitochondrial toxicity (lactic acidosis & hepatic steatosis)
Telaprevir Class
Use: Effective suppression of HBV DNA, normalization of ALT & reducing HBeAg. Adults only
IFN alfacon-1 class
P-kinetics: Oral bioavailability increased with high-fat meal, decreased with antacid.
Group MOA cont: Associated with mitochondrial DNA toxicity (by inhibiting DNA polymerase gamma)
PEG-IFN α-2a Class
HintAnswer
P-kinetics: Lipophilic (pivoxil) moiety enhances oral bioavailability.
P-kinetics:Oral bioavailability not affected by food. Emergence of resistance in long term use.
P-kinetics: Slower clearance (less frequent dosing). Dosage adjustment is needed in renal dysfunction
Lamivudine (3TC, Heptovir) Class
Telbivudine (Tyzeka) Class
Contraindications: Pts w/ uncorrected anemia, ESRD, preggo. Teratogenic: avoid pregnancy for > 6 mos thereafter
IFN α-2b Class
Contraindications: Hepatic decompensation, autoimmune dz, cardiac arrhythmia, pregnancy
MOA: Serine protease inhibitors. Bind to inhibit HCV non-structural protein NS3
Boceprevir Class
Drug MOA: PEG = polyethylene glycol
P-kinetics: Clinical resistance is rare. Oral bioavailability decreased by food (taken w/ empty stomach). Renal elimination (serum concentration increased w/ altered kidney activit
Use: Improve therapeutic response in pts (>18 yo) w/ HCV genotype 1 when combined w/ IFN/ribavirin
P-kinetics: Natural. SC or IM
P-kinetics: Synthetic (consensus). SC
Group MOA cont. (3) Protein kinase (activated by dsRNA): phosphorylates/inhibits eIF-2, therefore blocking PRO synthesis
MOA: A prodrug of adefovir (adenosine analogue). Slows suppression of HBV DNA; least seroconversion
Use: HBV: Safer for pts w/ decompensated liver dz. For both adults & peds
P-kinetics: Higher rate of complete response & less resistance vs. adefovir
P-kinetics: Prolonged intracellular half-life in HBV (than in HIV). Rapid oral absorption; eliminated unchanged. Used at lower doses for hepatitis than for AIDS.
SE: Flu-like symptoms (fever, chills, myalgias, malaise). Neurotoxicity, myelosuppression, fatigue (chronic use). Transient hepatic enzyme elevation.
MOA: A prodrug (a guanosine nucleoside analogue). Phosphorylated by host cell enzymes; inhibits viral RNA-dependent polymerases.
SE: Dose-dependent hemolytic anemia. Depression, fatigue, irritability, nausea, insomnia.
Entecavir (Baraclude) Class
SE: Nephrotoxicity (at high doses). Potential mitochondrial DNA toxicity

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras